Rezvilutamide for metastatic hormone-sensitive prostate cancer

被引：0
|
作者：
Ye, Dingwei [1 ,2 ]
Gu, Weijie [1 ,2 ]
Li, Junliang [3 ]
机构：
[1] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China
[3] Jiangsu Hengrui Pharmaceut, Clin Res & Dev, Shanghai, Peoples R China
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E491 / E491
页数：1
相关论文
共 50 条
  • [31] Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer
    Ajjai Alva
    Maha Hussain
    Drugs, 2013, 73 : 1517 - 1524
  • [32] Metastatic hormone-sensitive prostate cancer: How should it be treated?
    Lopez-Campos, Fernando
    Gonzalez-San Segundo, Carmen
    Conde-Moreno, Antonio Jose
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (02): : 43 - 49
  • [33] Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
    Wala, Jeremiah
    Nguyen, Paul
    Pomerantz, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (20) : 3584 - +
  • [34] Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 (5) : 801 - 801
  • [35] Metastatic hormone-sensitive prostate cancer: local treatment strategies
    Montorsi, Francesco
    Martini, Alberto
    Gandaglia, Giorgio
    Fossati, Nicola
    Stabile, Armando
    Deho, Federico
    Salonia, Andrea
    Briganti, Alberto
    WORLD JOURNAL OF UROLOGY, 2022, 40 (03) : 881 - 882
  • [36] Metastatic hormone-sensitive prostate cancer: local treatment strategies
    Francesco Montorsi
    Alberto Martini
    Giorgio Gandaglia
    Nicola Fossati
    Armando Stabile
    Federico Dehò
    Andrea Salonia
    Alberto Briganti
    World Journal of Urology, 2022, 40 : 881 - 882
  • [37] Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer
    Alva, Ajjai
    Hussain, Maha
    DRUGS, 2013, 73 (14) : 1517 - 1524
  • [38] Double or Triple Trouble in Metastatic Hormone-sensitive Prostate Cancer?
    Kostos, Louise
    Murphy, Declan G.
    Azad, Arun A.
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 503 - 504
  • [39] Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
    Cattrini, Carlo
    Castro, Elena
    Lozano, Rebeca
    Zanardi, Elisa
    Rubagotti, Alessandra
    Boccardo, Francesco
    Olmos, David
    CANCERS, 2019, 11 (09)
  • [40] Xtandi® Extensive care in hormone-sensitive metastatic prostate cancer
    不详
    ACTUALITES PHARMACEUTIQUES, 2022, 61 (616): : 9 - 9
12345